日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Selective inhibition of human 3β-hydroxysteroid dehydrogenase type 1 as a potential treatment for breast cancer.

选择性抑制人类 3β-羟基类固醇脱氢酶 1 型作为乳腺癌的潜在治疗方法

Thomas James L, Bucholtz Kevin M, Kacsoh Balint

The functions of key residues in the inhibitor, substrate and cofactor sites of human 3beta-hydroxysteroid dehydrogenase type 1 are validated by mutagenesis

通过诱变实验验证了人3β-羟基类固醇脱氢酶1型抑制剂、底物和辅因子位点中关键残基的功能

Thomas, James L; Mack, Vance L; Sun, Jingping; Terrell, J Ross; Bucholtz, Kevin M

Structural basis for the selective inhibition of human 3beta-hydroxysteroid dehydrogenase 1 in human breast tumor MCF-7 cells.

人乳腺肿瘤 MCF-7 细胞中人 3β-羟基类固醇脱氢酶 1 选择性抑制的结构基础

Thomas James L, Bucholtz Kevin M, Sun Jingping, Mack Vance L, Kacsoh Balint

Structure/function of the inhibition of human 3beta-hydroxysteroid dehydrogenase type 1 and type 2 by trilostane

曲洛司坦对人3β-羟基类固醇脱氢酶1型和2型抑制的结构/功能

Thomas, James L; Mack, Vance L; Glow, Jason A; Moshkelani, Delaram; Terrell, J Ross; Bucholtz, Kevin M